Skip to main content

NNOX · Nano-X Imaging Ltd.

Track NNOX — free
$0.65 +0.01 (+1.09%)
Market Cap
$50.31M
Shares
78.59M
Volume · Oct 5 692.6K Avg daily vol (3M) 1.18M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.64 Open$0.63 Day$0.62–0.65 52W close$0.63–4.55 Avg vol 30d1.3M Short int6.8M · 8.6% float · 3.4d Short vol63% Last earningsSep 9, 2026 DataAug 2020–Oct 2026

Up next

Next earnings call
Dec 2, 2026 Est · unconfirmed · in 8 wks
call held Sep 9, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+15.4%
Year over year
Operating margin
-600.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+10.4%
Year over year · more shares
Price change (1Y)
-83.2%
Trailing year
Short interest
8.6%
Latest settlement · 3.4 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −65%
below
Price vs 50-day avg −23%
below
RSI (14) 38
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −23%
trailing
6-month return −74%
trailing
YTD return −77%
this year
Relative strength −86%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
-21% holders QoQ · +22 funds added
Insider flow Accumulating
Net +$179.4K over 90 days · 0% sells
Short interest Rising
8.60% of float · ▲ +4.6% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
101 holders — near 3-yr low, contrarian setup
Squeeze score 62
elevated · 0–100
Fundamentals
Weak
Revenue growth +15%
Y/Y
Gross margin -98%
contracting
EPS growth −27%
Y/Y
Free cash flow $-45.0M
Quant / Vol
risk profile
Very High
Volatility 99%
annualized · 1-yr
Max drawdown −86%
past year
ATR 10.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Sep 9, 2026
Annualized cost savings · beginning in 2027 $2M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−65% Bearish
Price vs 50-day avg
−23% Bearish
RSI (14)
38 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
-21% holders QoQ · +22 funds added
Insider flow Accumulating
Net +$179.4K over 90 days · 0% sells
Short interest Rising
8.60% of float · ▲ +4.6% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
101 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $1 · 0% Range high $5
vs 200-day avg -65% vs 50-day avg -23%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NNOX
Nano-X Imaging Ltd.
this stock
$50.31M -77.0% +15.4% — 8.6%
ABT
Abbott Laboratories
$174.90B -20.1% +5.7% 28.1 1.1%
MDT
Medtronic plc
$113.38B -8.4% +8.4% 21.8 1.3%
SYK
Stryker Corp
$104.47B -18.8% +11.2% 28.2 2.0%
BSX
Boston Scientific Corp
$63.59B -55.5% +12.5% 17.8 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
101
% held
12.8%
Net QoQ
-8.8M sh
Top holder
UBS Group AG
Held Float
View
Held by Funds
Fund positions
12
View
Short & Settlement
Short Interest Rising
Shares short
6.8M
Days to cover
3.4d
Change
+299.8K sh
View
Short Volume
Short vol %
63%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$1
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
59.1%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$179.4K
Buyers / Sellers
3 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$13.0M
Net income (FY)
$-75.0M
EPS diluted
$-1.16
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 2, 2026
This year
14
View
Proposed Sales
Value
$5.8K
Shares
6.0K
Filed
Aug 4, 2026
View
Earnings & Events
Webcasts
Last webcast
Sep 9, 2026
View

Performance

5D 20D 120D MTD YTD
NNOX +1.7% -22.5% -74.0% -7.3% -77.0%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY +0.5% -23.1% -85.5% -8.9% -90.7%
Key facts CIK 1795251 CUSIP M70700105 13F (30d) 6 filings 4 filers Visit website Investor relations